113 related articles for article (PubMed ID: 37640192)
1. Integration analysis using bioinformatics and experimental validation on the clinical and biological significance of TSLP in cancers.
Qu H; Liu X; Jiang T; Huang G; Cai H; Xing D; Mao Y; Zheng X
Cell Signal; 2023 Nov; 111():110874. PubMed ID: 37640192
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of SEC61G in lung adenocarcinoma: a comprehensive study based on bioinformatics and in vitro validation.
Zheng Q; Wang Z; Zhang M; Yu Y; Chen R; Lu T; Liu L; Ma J; Liu T; Zheng H; Li H; Li J
BMC Cancer; 2021 Nov; 21(1):1216. PubMed ID: 34774014
[TBL] [Abstract][Full Text] [Related]
3. Identification of CDT1 as a prognostic marker in human lung adenocarcinoma using bioinformatics approaches.
Jiang J; Zhang Y; Wang J; Yang X; Ren X; Huang H; Wang J; Lu J; Zhong Y; Lin Z; Lin X; Jia Y; Lin S
PeerJ; 2023; 11():e16166. PubMed ID: 37790630
[TBL] [Abstract][Full Text] [Related]
4. CASC5 is a potential tumour driving gene in lung adenocarcinoma.
Cui Y; Zhang C; Ma S; Guo W; Cao W; Guan F
Cell Biochem Funct; 2020 Aug; 38(6):733-742. PubMed ID: 32283571
[TBL] [Abstract][Full Text] [Related]
5. Pan-Cancer and Single-Cell Analysis Reveals CENPL as a Cancer Prognosis and Immune Infiltration-Related Biomarker.
Feng Z; Chen Y; Cai C; Tan J; Liu P; Chen Y; Shen H; Zeng S; Han Y
Front Immunol; 2022; 13():916594. PubMed ID: 35844598
[TBL] [Abstract][Full Text] [Related]
6. Multi-omics analysis of MRPL-13 as a tumor-promoting marker from pan-cancer to lung adenocarcinoma.
Zhong X; He Z; Fan Y; Yin L; Hong Z; Tong Y; Bi Q; Zhu S
Aging (Albany NY); 2023 Oct; 15(19):10640-10680. PubMed ID: 37827692
[TBL] [Abstract][Full Text] [Related]
7. Pan-cancer analysis of UBE2T with a focus on prognostic and immunological roles in lung adenocarcinoma.
Cao K; Ling X; Jiang X; Ma J; Zhu J
Respir Res; 2022 Nov; 23(1):306. PubMed ID: 36357897
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of BCCIP predicts an unfavorable prognosis and promotes the proliferation and migration of lung adenocarcinoma.
Shi J; Lv X; Li W; Ming Z; Zeng L; Yuan J; Chen Y; Liu B; Yang S
Thorac Cancer; 2021 Sep; 12(17):2324-2338. PubMed ID: 34297484
[TBL] [Abstract][Full Text] [Related]
9. Budding uninhibited by benzimidazoles 1 overexpression is associated with poor prognosis and malignant phenotype: A promising therapeutic target for lung adenocarcinoma.
Chen R; Wang Z; Lu T; Liu Y; Ji Y; Yu Y; Tou F; Guo S
Thorac Cancer; 2023 Apr; 14(10):893-912. PubMed ID: 36825773
[TBL] [Abstract][Full Text] [Related]
10. Pan-cancer landscape of CENPO and its underlying mechanism in LUAD.
Shi T; Hu Z; Tian L; Yang Y
Respir Res; 2023 Apr; 24(1):113. PubMed ID: 37061713
[TBL] [Abstract][Full Text] [Related]
11. Identification of immune-associated biomarker for predicting lung adenocarcinoma: bioinformatics analysis and experiment verification of PTK6.
Xiong RH; Yang SQ; Li JW; Shen XK; Jin LM; Chen CY; Yue YT; Yu ZC; Sun QY; Jiang W; Jiang MZ; Wang XY; Song SX; Cao D; Ye HL; Zhao LR; Huang LP; Bu L
Discov Oncol; 2024 Apr; 15(1):102. PubMed ID: 38573548
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of ERCC6L correlates with poor prognosis and confers malignant phenotypes of lung adenocarcinoma.
Huang X; Jiang L; Lu S; Yuan M; Lin H; Li B; Wen Z; Zhong Y
Oncol Rep; 2022 Jul; 48(1):. PubMed ID: 35656882
[TBL] [Abstract][Full Text] [Related]
13. KIAA1429 promotes the progression of lung adenocarcinoma by regulating the m6A level of MUC3A.
Zhao W; Xie Y
Pathol Res Pract; 2021 Jan; 217():153284. PubMed ID: 33249400
[TBL] [Abstract][Full Text] [Related]
14. CircPRKCI regulates proliferation, migration and cycle of lung adenocarcinoma cells by targeting miR-219a-5p-regulated CAMK1D.
Sui MH; Zhang WW; Geng DM; Sun DJ
Eur Rev Med Pharmacol Sci; 2021 Feb; 25(4):1899-1909. PubMed ID: 33660800
[TBL] [Abstract][Full Text] [Related]
15. Human Lung-Resident Macrophages Express and Are Targets of Thymic Stromal Lymphopoietin in the Tumor Microenvironment.
Braile M; Fiorelli A; Sorriento D; Di Crescenzo RM; Galdiero MR; Marone G; Santini M; Varricchi G; Loffredo S
Cells; 2021 Aug; 10(8):. PubMed ID: 34440780
[TBL] [Abstract][Full Text] [Related]
16. CA916798 predicts poor prognosis and promotes Gefitinib resistance for lung adenocarcinoma.
He J; Lan X; Liu X; Deng C; Luo H; Wang Y; Kang P; Sun Z; Zhao L; Zhou X
BMC Cancer; 2023 Mar; 23(1):266. PubMed ID: 36959566
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of CENPF is associated with progression and poor prognosis of lung adenocarcinoma.
Li MX; Zhang MY; Dong HH; Li AJ; Teng HF; Liu AL; Xu N; Qu YQ
Int J Med Sci; 2021; 18(2):494-504. PubMed ID: 33390818
[No Abstract] [Full Text] [Related]
18. Overexpression of thymic stromal lymphopoietin is correlated with poor prognosis in epithelial ovarian carcinoma.
Xu L; Guo Y; Xu N; Chen L; Zhu J; Liu N; Zhang ZY
Biosci Rep; 2019 May; 39(5):. PubMed ID: 31023965
[TBL] [Abstract][Full Text] [Related]
19. Identification of a novel prognosis-associated ceRNA network in lung adenocarcinoma via bioinformatics analysis.
Li Y; Yu X; Zhang Y; Wang X; Zhao L; Liu D; Zhao G; Gao X; Fu J; Zang A; Jia Y
Biomed Eng Online; 2021 Nov; 20(1):117. PubMed ID: 34819106
[TBL] [Abstract][Full Text] [Related]
20. miR-139-5p Inhibits Lung Adenocarcinoma Cell Proliferation, Migration, and Invasion by Targeting MAD2L1.
Li J; He X; Wu X; Liu X; Huang Y; Gong Y
Comput Math Methods Med; 2020; 2020():2953598. PubMed ID: 33204298
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]